These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 760920)

  • 1. The outcome of severe acute schizophrenic illnesses after one year.
    Johnstone EC; Frith CD; Gold A; Stevens M
    Br J Psychiatry; 1979 Jan; 134():28-33. PubMed ID: 760920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Scottish first episode schizophrenia study. VII. Two-year follow-up. Scottish Schizophrenia Research Group.
    McCreadie RG; Wiles D; Grant S; Crockett GT; Mahmood Z; Livingston MG; Watt JA; Greene JG; Kershaw PW; Todd NA
    Acta Psychiatr Scand; 1989 Dec; 80(6):597-602. PubMed ID: 2694767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a 50% reduction of cis(z)-flupenthixol decanoate in chronic schizophrenic patients maintained on a high dose regime.
    Cookson IB
    Int Clin Psychopharmacol; 1987 Apr; 2(2):141-9. PubMed ID: 3298419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Scottish First Episode Schizophrenia Study V. One-year follow-up. The Scottish Schizophrenia Research Group.
    Br J Psychiatry; 1988 Apr; 152():470-6. PubMed ID: 3167396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixol.
    Joseph MH; Baker HF; Johnstone EC; Crow TJ
    Psychopharmacology (Berl); 1979 Jun; 64(1):35-40. PubMed ID: 113829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
    Knights A; Okasha MS; Salih MA; Hirsch SR
    Br J Psychiatry; 1979 Dec; 135():515-23. PubMed ID: 394794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial of flupenthixol decanoate in chronic withdrawn schizophrenic patients.
    Vichaiya V
    J Med Assoc Thai; 1980 Apr; 63(4):205-9. PubMed ID: 6991627
    [No Abstract]   [Full Text] [Related]  

  • 8. Flupenthixol versus haloperidol in acute psychosis.
    Parent M; Toussaint C
    Pharmatherapeutica; 1983; 3(5):354-64. PubMed ID: 6844372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects of anticholinergic medication on positive schizophrenic symptoms.
    Johnstone EC; Crow TJ; Ferrier IN; Frith CD; Owens DG; Bourne RC; Gamble SJ
    Psychol Med; 1983 Aug; 13(3):513-27. PubMed ID: 6413994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia.
    Kelly HB; Freeman HL; Banning B; Schiff AA
    Int Pharmacopsychiatry; 1977; 12(1):54-64. PubMed ID: 406212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences.
    Johnson DA; Pasterski G; Ludlow JM; Street K; Taylor RD
    Acta Psychiatr Scand; 1983 May; 67(5):339-52. PubMed ID: 6135298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group.
    Br J Psychiatry; 1987 Mar; 150():334-8. PubMed ID: 2889495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
    Ehmann TS; Delva NJ; Beninger RJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flupenthixol versus haloperidol in acute psychotic episodes].
    Parent M; Toussaint C
    Acta Psychiatr Belg; 1982; 82(6):617-31. PubMed ID: 7183131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.
    Johnstone EC; Crow TJ; Frith CD; Carney MW; Price JS
    Lancet; 1978 Apr; 1(8069):848-51. PubMed ID: 76797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS; Yeo SH
    Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin conductance responsivity during acute episodes of schizophrenia as a predictor of symptomatic improvement.
    Frith CD; Stevens M; Johnstone EC; Crow TJ
    Psychol Med; 1979 Feb; 9(1):101-6. PubMed ID: 424477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical effects of the isomers of flupenthixol--the consequences of dopamine receptor blockade in acute schizophrenia [proceedings].
    Crow TJ; Frith C; Johnstone EC
    Br J Clin Pharmacol; 1977 Oct; 4(5):648P. PubMed ID: 911634
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication.
    Cotes PM; Crow TJ; Johnstone EC; Bartlett W; Bourne RC
    Psychol Med; 1978 Nov; 8(4):657-65. PubMed ID: 364517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the effects of fluphenazine-depot and flupenthixol-depot in the treatment of schizophrenic psychoses].
    Bilikiewicz A; Sep-Kowalikowa B
    Psychiatr Pol; 1976; 10(4):359-66. PubMed ID: 981411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.